Dolby Laboratories Inc. (DLB) Tops Q3 EPS by 11c; Issues Very Strong FY11 Outlook; Announces $250M Buyback; Trading Halted
Tweet
Share
E-mailGet Alerts DLB Hot Sheet
Price: $62.19 +1.30%
Financial Fact:
Interest income: 1.67M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest income: 1.67M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Dolby Laboratories Inc. (NYSE: DLB) reported Q3 EPS of $0.65, $0.11 better than the analyst estimate of $0.54. Revenue for the quarter came in at $219 million versus the consensus estimate of $216.1 million.
Dolby Laboratories Inc. sees FY2011 EPS of $2.87-$2.96, versus the consensus of $2.60. Dolby Laboratories Inc. sees FY2011 revenue of $930-$955 million, versus the consensus of $932.18 million.
Announces a $250 million buyback plan.
Dolby Laboratories Inc. sees FY2011 EPS of $2.87-$2.96, versus the consensus of $2.60. Dolby Laboratories Inc. sees FY2011 revenue of $930-$955 million, versus the consensus of $932.18 million.
Announces a $250 million buyback plan.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- CapsoVision (CV) Misses Q2 EPS by 4c
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Stock Buybacks, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
